全文获取类型
收费全文 | 1207篇 |
免费 | 63篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 44篇 |
妇产科学 | 6篇 |
基础医学 | 63篇 |
口腔科学 | 13篇 |
临床医学 | 174篇 |
内科学 | 373篇 |
皮肤病学 | 17篇 |
神经病学 | 60篇 |
特种医学 | 245篇 |
外科学 | 117篇 |
综合类 | 47篇 |
预防医学 | 40篇 |
眼科学 | 31篇 |
药学 | 49篇 |
中国医学 | 2篇 |
肿瘤学 | 21篇 |
出版年
2022年 | 4篇 |
2021年 | 14篇 |
2020年 | 3篇 |
2019年 | 8篇 |
2018年 | 21篇 |
2017年 | 10篇 |
2016年 | 15篇 |
2015年 | 26篇 |
2014年 | 27篇 |
2013年 | 40篇 |
2012年 | 47篇 |
2011年 | 30篇 |
2010年 | 30篇 |
2009年 | 29篇 |
2008年 | 29篇 |
2007年 | 63篇 |
2006年 | 24篇 |
2005年 | 37篇 |
2004年 | 34篇 |
2003年 | 36篇 |
2002年 | 27篇 |
2001年 | 29篇 |
2000年 | 30篇 |
1999年 | 36篇 |
1998年 | 56篇 |
1997年 | 40篇 |
1996年 | 63篇 |
1995年 | 46篇 |
1994年 | 42篇 |
1993年 | 52篇 |
1992年 | 15篇 |
1991年 | 19篇 |
1990年 | 25篇 |
1989年 | 35篇 |
1988年 | 44篇 |
1987年 | 39篇 |
1986年 | 29篇 |
1985年 | 32篇 |
1984年 | 19篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 26篇 |
1980年 | 19篇 |
1979年 | 7篇 |
1978年 | 10篇 |
1977年 | 15篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1970年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有1329条查询结果,搜索用时 0 毫秒
41.
42.
Steven R. Steinhubl John W. Eikelboom Elaine M. Hylek Harold L. Dauerman Susan S. Smyth Richard C. Becker 《Journal of thrombosis and thrombolysis》2014,37(3):362-371
The contribution of platelets in the pathophysiology of low-shear thrombosis—specifically, in atrial fibrillation (AF) and venous thromboembolic events (VTE)—remains less clear than for arterial thrombosis. AF itself appears to lead to platelet activation, offering a potential target for aspirin and other antiplatelet agents. Randomized trial results suggest a small benefit of aspirin over placebo, and of dual antiplatelet therapy (aspirin plus clopidogrel) over aspirin alone, for prevention of cardioembolic events in AF. Antiplatelet therapy thus can represent an option for patients with AF who are unsuitable for therapy with warfarin or novel oral anticoagulant agents. For VTE, the rationale for antiplatelet therapy reflects the venous response to disrupted blood flow—interactions among monocytes, neutrophil extracellular traps, and platelets. Early randomized trials generally showed poorer performance of aspirin relative to heparins and danaparoid sodium in prevention of VTE. However, results from large placebo- and dalteparin-controlled randomized trials have spurred changes in the most recent practice guidelines—aspirin is now recommended after major orthopedic surgery for patients who cannot receive other antithrombotic therapies. 相似文献
43.
Jasper G Gerbers Martin Stevens Joris JW Ploegmakers Sjoerd K Bulstra Paul C Jutte 《Acta orthopaedica》2014,85(6):663-669
Background and purpose —
In orthopedic oncology, computer-assisted surgery (CAS) can be considered an alternative to fluoroscopy and direct measurement for orientation, planning, and margin control. However, only small case series reporting specific applications have been published. We therefore describe possible applications of CAS and report preliminary results in 130 procedures.Patients and methods —
We conducted a retrospective cohort study of all oncological CAS procedures in a single institution from November 2006 to March 2013. Mean follow-up time was 32 months. We categorized and analyzed 130 procedures for clinical parameters. The categories were image-based intralesional treatment, image-based resection, image-based resection and reconstruction, and imageless resection and reconstruction.Results —
Application to intralesional treatment showed 1 inadequate curettage and 1 (other) recurrence in 63 cases. Image-based resections in 42 cases showed 40 R0 margins; 16 in 17 pelvic resections. Image-based reconstruction facilitated graft creation with a mean reconstruction accuracy of 0.9 mm in one case. Imageless CAS was helpful in resection planning and length- and joint line reconstruction for tumor prostheses.Interpretation —
CAS is a promising new development. Preliminary results show a high number of R0 resections and low short-term recurrence rates for curettage.Oncological surgical treatment can be considered to be a trade-off between margins and function, with margins being the most important factor to consider. Accuracy is needed to achieve an efficient but oncologically safe result. To assist in this, most procedures in bone tumor surgery require intraoperative imaging with fluoroscopy and/or measurements with rulers for anatomical orientation and margin control. The best examples of this are pelvic resections. Cartiaux et al. (2008) demonstrated that 4 experienced surgeons could achieve a 10-mm resection margin, with 5-mm tolerance, on pelvic sawbones in only half of the resections. The supportive imaging and measuring modalities have, however, remained more or less unchanged for many years. In a 2-dimensional (2D) workflow such as fluoroscopy, there is still the requirement for an accurate frame of reference based on anatomical landmarks for adequate 3-dimensional (3D) margin control.In recent years, the use of computer-assisted surgery (CAS) in orthopedic surgery has become more common as an alternative for intraoperative imaging and measurements, providing the necessary precision in bone tumor surgery. The technique that is mostly used in orthopedic oncology is image-based navigation. The patient’s own anatomy (MRI and/or CT) is entered into the system and used during surgery. This provides real-time, continuous, 3D imaging feedback and may lead to more precise margin control, better tissue preservation, and new approaches to reconstruction while remaining oncologically safe. Several publications have supported CAS as being a safe navigation platform for planning and performing resections (Wong et al. 2007, So et al. 2010, Cho et al. 2012). A recent publication describes lessons in the technological approach and offers comments on CAS workflow (Wong 2010). However, to date the largest case series have involved only 20 and 31 cases (Cheong and Letson 2011, Jeys et al. 2013). The reported use has mostly been limited to complex tumor resections (e.g. pelvic), and due to the novelty of the technique, applications, approaches, and set-up times differ greatly (Saidi 2012). Here we describe possible applications of CAS in bone tumor surgery (also outside of complex resections), consider their usefulness, and report preliminary results from 130 CAS procedures performed at a single institution. 相似文献44.
Antiplatelet therapy is effective for reducing the risk of recurrent stroke and other serious vascular events in patients with recent TIA and ischemic stroke. Effective antiplatelet agents include aspirin, ticlopidine, clopidogrel, dipyridamole, and the combination of aspirin and dipyridamole. The combination of aspirin and clopidogrel is more effective than aspirin in patients with acute coronary syndrome but is more hazardous than clopidogrel alone in patients with recent TIA and ischemic stroke. Further trials are needed to determine whether the combination of aspirin and clopidogrel may have a role immediately after TIA and ischemic stroke in patients with symptomatic large artery atherothromboembolism and continued for approximately 3 months before switching to less hazardous antiplatelet regimens. 相似文献
45.
清开灵与利巴韦林治疗小儿呼吸道合胞病毒肺炎的比较:单盲、随机、平行对照试验 总被引:1,自引:0,他引:1
目的:比较清开灵与利巴韦林对呼吸道合胞病毒肺炎患儿治疗效果的差异。方法:选择2005-02/2006-04在北京儿童医院分中心治疗的小儿呼吸道合胞病毒肺炎97例,患儿法定监护人知情同意。采用单盲、随机、平行对照试验的原则,按区组随机化方法分为2组,清开灵注射液组49例,利巴韦林组48例。①清开灵注射液组:清开灵注射液静脉滴注加口服中成药。②利巴韦林组:利巴韦林注射液静脉滴注加口服复方愈创木酚磺酸钾口服液。两组疗程均为10d,比较两组患儿的疗效。结果:清开灵注射液组脱落3例,利巴韦林组脱落1例,进入结果分析清开灵注射液组46例,利巴韦林组47例。①清开灵注射液组发热患儿体温恢复正常时间比利巴韦林组短[(2.72±1.86)d,(6.29±2.41)d(P<0.01)]。②清开灵注射液组患儿咳嗽、痰壅、气促症状积分改善方面优于利巴韦林组(P<0.05~0.01)。③清开灵注射液组的呼吸道合胞病毒转阴时间明显优于利巴韦林组。④咳嗽、痰壅、病毒转阴时间、气促均进入Logistic模型,其中前两个症状的回归系数绝对值较大。结论:清开灵注射液治疗小儿呼吸道合胞病毒肺炎在退热、止咳平喘、呼吸道合胞病毒转阴时间等方面均具有明显优势,咳嗽、痰壅这两个症状更能反映清开灵注射液的疗效优于利巴韦林。 相似文献
46.
人羊膜间充质细胞具有分化成软骨及成骨细胞的潜能 总被引:1,自引:0,他引:1
目的:人羊膜间充质细胞具有比骨髓间充质干细胞更强的扩增能力和免疫原性低等优势。建立体外适宜的诱导培养条件,观察人羊膜间充质细胞定向分化为软骨细胞和成骨细胞的能力。方法:实验于2005-09/2006-12在贵州省细胞工程重点实验室完成。①材料来源:经产妇知情同意,无菌采集健康足月分娩新生儿胎盘6份,实验经医院医学伦理委员会批准。②实验方法:采用机械法剥离羊膜组织,二步酶消化法分离收获人羊膜间充质细胞,按2.2×10~8L~(-1)密度接种,传至第1~2代用于诱导分化实验。向软骨细胞诱导分化时,人羊膜间充质细胞按3×10~8L~(-1)密度接种,诱导培养液为含体积分数0.01的胎牛血清、10 mg/L转化生长因β1、100 nmol/L地塞米松、50 mg/L抗坏血酸、1%培养基添加物。向成骨细胞诱导分化时,人羊膜间充质细胞按6×10~7L~(-1)密度接种,诱导培养液为含体积分数0.1的胎牛血清、100 nmol/L地塞米松、50 mg/L抗坏血酸、5 mmol/Lβ-甘油磷酸。③实验评估:原代细胞用流式细胞仪分析表型,免疫细胞化学染色进行波形蛋白表达鉴定。分别于体外诱导第7,14,21,28天采用免疫细胞化学法检测软骨特异性Ⅱ型胶原的表达,细胞化学法检测蛋白聚糖的表达,钙-钴法检测成骨细胞特异性碱性磷酸酶的表达,茜素红S检测钙盐沉积情况。结果:①免疫组化与表型特征:人羊膜间充质细胞高表达间充质干细胞表面标志CD29、CD44和间充质细胞标志波形蛋白。②向软骨细胞诱导分化:诱导14 d后,人羊膜间充质细胞由长梭型逐渐变为多角形,可检测到Ⅱ型胶原蛋白表达及软骨细胞特异性细胞外基质蛋白聚糖。③向成骨细胞诱导分化:诱导21 d后,可观察到人羊膜间充质细胞的胞浆内有碱性磷酸酶表达,且可见钙盐沉积。结论:人羊膜间充质细胞具有分化成软骨细胞和成骨细胞的特性,可作为骨及软骨组织工程种子细胞的新来源。 相似文献
47.
The incidence of symptoms at the moment the internal carotid artery (ICA) occludes was assessed in 33 patients. Duplex scanning was performed to determine the progression from stenosis to ICA occlusion. There were 24 patients with a primary stenosis and nine with a restenosis after a carotid endarterectomy. In 18% (6/33) the occlusion was accompanied by a stroke. A transient ischaemic attack (TIA) was seen in 12% (4/33) of patients and 70% (23/33) remained asymptomatic. There was no difference in stroke rate between patients with primary stenosis (4/24:17%) and those with restenosis (2/9:22%). The mean follow-up was 3.2 years and the mean elapse time to occlusion in patients with a stroke was 20 months, with a TIA, 32 months, and in asymptomatic patients, 44 months. It was also shown that a stenosis of greater than 80% diameter reduction had a faster progression (mean 1 year) than a less than 80% stenosis (mean 3.5 years) (p = 0.04). Patients with a stenosis greater than 80% tended to have a higher incidence (40%:2/5) of stroke at the time of occlusion than patients with a stenosis less than 80% (14%:2/28). The results show that an occlusion of the ICA is accompanied by a stroke in 18% of the cases and that patients with a rapid progression and/or greater than 80% stenosis are at high risk. From this point of view a carotid endarterectomy should be considered in order to prevent an occlusion of the ICA and a high risk of stroke. 相似文献
48.
E R Hammacher B C Eikelboom H J van Lier S H Skotnicki P F Wijn 《European journal of vascular surgery》1988,2(3):145-149
In a prospective study the incidence of brachial artery injury after cardiac catheterisation and the factors involved were examined. The main aim of the study however was to determine whether immediately after the injury it was possible to predict if long-term ischaemic symptoms would occur if conservative treatment was used. Five-hundred and two patients were seen pre- and post-catheterisation. Examination included inspection, palpation, segmental blood pressure measurements before and after exercise, Doppler score evaluation and in selected cases, angiography. Twenty-nine patients (5.8%) had postcatheterisation complaints of pain, pallor, hypoaesthesia or paraesthesia. A postcatheterisation wrist blood pressure index of less than 0.85, was found in 97 patients (19%). This included 22 occlusions confirmed by angiography (4.5%). Cardiac valve disease and previous catheterisations were a risk factor. All brachial artery injuries, that is to say those patients with a postcatheterisation wrist index of less than 0.85, were treated conservatively and reviewed at 6 months. Nineteen of the 72 patients seen at follow-up still had ischaemic symptoms on effort. Postinjury complaints of pain and paraesthesia had no value in predicting whether or not ischaemic symptoms would persist, whilst angiography, wrist pulse palpation, capillary refill time and the wrist pressure index at rest had very little predictive value. The Doppler score, pallor and coldness of the hand all had some value. The best predictor of long-term ischaemic symptoms was the wrist pressure index after exercise. Brachial artery injury occurs frequently after cardiac catheterisation and ischaemic symptoms thereafter are usually mild.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
49.
50.
Plaque disruption, platelet activation, and intracoronary artery thrombus formation are the key events in the pathogenesis of acute coronary syndromes. Antiplatelet therapies significantly reduce the risk of ischemic complications both during the acute phase and in the long term in patients with acute coronary syndromes. Aspirin remains the cornerstone of antiplatelet therapy, but there is incremental benefit when clopidogrel or ticlopidine is added to aspirin. Dual antiplatelet therapy with the combination of clopidogrel and aspirin is becoming the new standard of care for the management of patients with non-ST-segment elevation acute coronary syndrome and undergoing percutaneous coronary intervention and is currently being further evaluated in ST-segment elevation acute coronary syndrome. 相似文献